Display options
Cite
Stojanovic M, Raskovic S, Milivojevic V, et al. Enhanced Liver Fibrosis Score as a Biomarker for Vascular Damage Assessment in Patients with Takayasu Arteritis-A Pilot Study. J Cardiovasc Dev Dis. 2021;8(12)doi: 10.3390/jcdd8120187.
Stojanovic, M., Raskovic, S., Milivojevic, V., Miskovic, R., Soldatovic, I., Stankovic, S., Rankovic, I., Stankovic Stanojevic, M., Dragasevic, S., Krstic, M., & Diamantopoulos, A. P. (2021). Enhanced Liver Fibrosis Score as a Biomarker for Vascular Damage Assessment in Patients with Takayasu Arteritis-A Pilot Study. Journal of cardiovascular development and disease, 8(12), . https://doi.org/10.3390/jcdd8120187
Stojanovic, Maja, et al. "Enhanced Liver Fibrosis Score as a Biomarker for Vascular Damage Assessment in Patients with Takayasu Arteritis-A Pilot Study." Journal of cardiovascular development and disease vol. 8,12 (2021). doi: https://doi.org/10.3390/jcdd8120187
Stojanovic M, Raskovic S, Milivojevic V, Miskovic R, Soldatovic I, Stankovic S, Rankovic I, Stankovic Stanojevic M, Dragasevic S, Krstic M, Diamantopoulos AP. Enhanced Liver Fibrosis Score as a Biomarker for Vascular Damage Assessment in Patients with Takayasu Arteritis-A Pilot Study. J Cardiovasc Dev Dis. 2021 Dec 14;8(12). doi: 10.3390/jcdd8120187. PMID: 34940542; PMCID: PMC8709028.
Copy Download .nbib Format: NLM
Share it on

J Cardiovasc Dev Dis. 2021 Dec 14;8(12). doi: 10.3390/jcdd8120187.

Enhanced Liver Fibrosis Score as a Biomarker for Vascular Damage Assessment in Patients with Takayasu Arteritis-A Pilot Study.

Journal of cardiovascular development and disease

Maja Stojanovic, Sanvila Raskovic, Vladimir Milivojevic, Rada Miskovic, Ivan Soldatovic, Sanja Stankovic, Ivan Rankovic, Marija Stankovic Stanojevic, Sanja Dragasevic, Miodrag Krstic, Andreas P Diamantopoulos

Affiliations

  1. Clinic for Allergy and Immunology, University Clinical Center of Serbia, Koste Todorovica 2, 11000 Belgrade, Serbia.
  2. Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
  3. Clinic of Gastroenterohepatology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
  4. Institute of Medical Statistics and Informatic, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
  5. Center for Medical Biochemistry, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
  6. Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
  7. Department of Pathophysiology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
  8. Department of Rheumatology, Akershus University Hospital, 1478 Lørenskog, Norway.

PMID: 34940542 PMCID: PMC8709028 DOI: 10.3390/jcdd8120187

Abstract

Takayasu Arteritis (TA) is characterized by granulomatous panarteritis, vessel wall fibrosis, and irreversible vascular impairment. The aim of this study is to explore the usefulness of the Enhanced Liver Fibrosis score (ELF), procollagen-III aminoterminal propeptide (PIIINP), tissue inhibitor of matrix metalloproteinase-1 (TIMP-1), and hyaluronic acid (HA) in assessing vascular damage in TA patients. ELF, PIIINP, TIMP-1, and HA were measured in 24 TA patients, and the results were correlated with the clinical damage indexes (VDI and TADS), an imaging damage score (CARDS), and disease activity scores (NIH and ITAS2010). A mean ELF score 8.42 (±1.12) and values higher than 7.7 (cut-off for liver fibrosis) in 21/24 (87.5%) of patients were detected. The VDI and TADS correlated significantly to ELF (

Keywords: ELF; Takayasu Arteritis; biomarkers; vascular damage; vasculitis

References

  1. Open Rheumatol J. 2017 Feb 28;11:23-29 - PubMed
  2. J Hepatol. 2013 Aug;59(2):236-42 - PubMed
  3. Int J Cardiol. 2010 Nov 19;145(2):286-288 - PubMed
  4. PLoS One. 2014 Mar 06;9(3):e90527 - PubMed
  5. Biomed Res Int. 2014;2014:827105 - PubMed
  6. Ann Rheum Dis. 2014 Mar;73(3):616-23 - PubMed
  7. Circ J. 2013;77(2):477-83 - PubMed
  8. J Mol Cell Cardiol. 2003 Sep;35(9):1105-12 - PubMed
  9. J Rheumatol. 2014 Jun;41(6):1183-9 - PubMed
  10. Arthritis Rheum. 1997 Feb;40(2):371-80 - PubMed
  11. Arch Med Res. 2012 Jul;43(5):406-10 - PubMed
  12. Int J Cardiol. 1996 Aug;54 Suppl:S155-63 - PubMed
  13. J Clin Pathol. 2002 Jul;55(7):481-6 - PubMed
  14. J Hepatol. 2007 May;46(5):955-75 - PubMed
  15. J Rheumatol. 2007 Jun;34(6):1357-71 - PubMed
  16. Clin Exp Rheumatol. 2018 Jan-Feb;36(1):62-72 - PubMed
  17. Immunity. 2006 Feb;24(2):179-89 - PubMed
  18. BMC Gastroenterol. 2010 Sep 09;10:103 - PubMed
  19. Circ Genom Precis Med. 2019 Jan;12(1):e002080 - PubMed
  20. J Autoimmun. 2019 May;99:39-47 - PubMed
  21. J Biol Chem. 2007 Nov 16;282(46):33671-33680 - PubMed
  22. Matrix Biol. 2015 May-Jul;44-46:247-54 - PubMed
  23. Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):139-145 - PubMed
  24. Ann Intern Med. 1994 Jun 1;120(11):919-29 - PubMed
  25. Ann Rheum Dis. 2015 Dec;74(12):2236-43 - PubMed
  26. Rheumatology (Oxford). 2013 Oct;52(10):1795-801 - PubMed
  27. Clin Exp Rheumatol. 2020 Nov-Dec;38(6):1102-1111 - PubMed
  28. Circulation. 2003 Sep 23;108(12):1469-73 - PubMed
  29. Circ Res. 2018 Aug 31;123(6):700-715 - PubMed
  30. Gastroenterology. 2004 Dec;127(6):1704-13 - PubMed
  31. Semin Arthritis Rheum. 2020 Aug;50(4):586-591 - PubMed
  32. Atherosclerosis. 2015 Apr;239(2):539-46 - PubMed
  33. Circulation. 1996 Mar 15;93(6):1141-7 - PubMed
  34. Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S86-91 - PubMed
  35. Scand J Rheumatol. 2020 Mar;49(2):161-162 - PubMed
  36. J Cell Biol. 1999 Feb 22;144(4):789-801 - PubMed
  37. Curr Rheumatol Rep. 2020 Aug 26;22(10):68 - PubMed
  38. Can J Cardiol. 2016 May;32(5):659-68 - PubMed
  39. J Rheumatol. 2020 Jul 1;47(7):1001-1010 - PubMed
  40. J Intern Med. 1997 Jul;242(1):27-33 - PubMed
  41. Rheumatology (Oxford). 2019 Feb 1;58(2):254-259 - PubMed
  42. Am Heart J. 2006 Jul;152(1):93.e1-6 - PubMed
  43. Clin Chem. 2008 Nov;54(11):1815-22 - PubMed
  44. Nat Rev Rheumatol. 2010 Jul;6(7):406-15 - PubMed
  45. J Surg Res. 2012 Apr;173(2):e63-72 - PubMed
  46. Arthritis Rheum. 1990 Aug;33(8):1129-34 - PubMed
  47. Cell Physiol Biochem. 2015;35(3):1137-50 - PubMed
  48. PLoS One. 2017 Aug 2;12(8):e0180629 - PubMed
  49. J Biol Chem. 2009 Apr 3;284(14):9083-92 - PubMed

Publication Types